ReleaseWire Connect

Rheumatoid Arthritis Therapeutics in Asia Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Modest Growth Despite Brand Erosion of Blockbuster Anti-TNFs

The Global Non-Sugar Sweeteners Market is accounted to be $13.4 billion in 2014 growing at a CAGR of 1.67% to reach $15.3 billion by 2022. North America has the utmost claim for non sugar sweeteners, and economic declaration for now is 65% of the entire demand followed by Europe and Asia Pacific regions.

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized

The Global Baby Food market is poised to reach $49.2 billion in 2014 growing at a CAGR of 8.95% to reach $97.7 billion by 2022. Some of the key drivers include altering socio-economic trends, mounting end user alertness as well as modern goods and binding. The matured industrialization and mass production of canned goods, growing importance of advertising and the discovery of vitamins in vegetables and fruits are boosting the market growth.

Remote Patient Monitoring Market to 2019 – Potential to Reduce Healthcare Cost Burden and Improve Quality of Care to Drive Future Growth" looks at the market, competitive landscape, and trends for the two remote patient monitoring market segments: implantable remote patient monitoring and external remote patient monitoring. The report provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape and gives a detailed analysis of each segment's pipeline products, as well as details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by our Research's team of industry experts.

The Global Compound Feed market accounted for $300.6 billion in 2014 growing at a CAGR of 8.17% it is expected to reach $563.3 billion by 2022. The compound feed industry plays a most vital role in food chain which provides feasible and healthy food.

Ovarian Cancer Therapeutics to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free Survival and Targeted Therapies". The current Ovarian cancer therapeutics market is dominated by the use of generics – predominately carboplatin and paclitaxel, which are used in combination for the treatment of platinum-sensitive disease (both first-line and recurrent). Initial treatment with platinum-based therapy is usually effective, with approximately 70% of patients entering remission. However, even with extended progression free-survival of 24 months, almost all patients relapse, and after successive periods of remission and relapse either die or progress to platinum-resistant disease, for which the prognosis is poor. There is a clear gap in the market for maintenance therapies to extend the initial high rates of remission, and hopefully stimulate long-term remission in patients. As well as a gap for more effective treatment options in platinum-resistant or refractory patients. The current developmental pipeline addresses these gaps in the market, with five of the 10 late stage pipeline molecules indicated as maintenance therapies, and three of the 10 indicated in platinum-resistant disease. However, efficacy with these late stage drugs has been poor, at best demonstrating minimal improvements in PFS.

Leading business intelligence provider, has released its latest research: Obesity Therapeutics to 2019 – Safety Concerns Hinder Drug Performance Despite Large Market Opportunity". Obesity is often described as a global endemic, with incidence dramatically increasing over the past decades, particularly in developed countries. Being overweight or obese is a major risk factor in the development of many chronic diseases, including cardiovascular diseases, cancer, and diabetes, of which treatment incurs extensive economic and healthcare costs.

The Global Sports Medicine Market is accounted $31.5 billion in 2014 and is expected to reach $53.6 billion in 2022 at a Compound Annual Growth Rate of 6.8%. Sports medicine is about preventing and treating the athletes and any other people indulged in physical activities from injuries. The Sports Medicine market is the sub set of the orthopedic market. Some of the key factors driving the market are increasing number of cases of sports injuries, gaining popularity of western sports and growing economies to raise the budget allotment for sports.

The Global Specialty Water Treatment Chemicals Market is valued at $26.2 billion in 2014 and is poised to reach $42.3 billion by 2022 growing at a Compound Annual Growth Rate (CAGR) of 6.2% from 2014 to 2022. The factors that are influencing the market growth are increasing demand for water and stringent environmental regulations.